AAX Biotech welcomes a new member to the Business Development team

🎉We’re excited to welcome Claudia Kielkopf, PhD as Business Development Manager to the AAX Biotech team! 🎉

Claudia brings deep technical understanding and strategic thinking to her role in AAX Biotech’s business development team led by our CBO Maria L. Knudsen.

Holding a PhD in protein biochemistry and structural biology, Claudia has postdoctoral research experience in structural and computational biology at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. She joins AAX Biotech with industrial R&D and commercial experience as product lead at Ionlace, a therapeutic antibody development start-up.

Claudia is an excellent communicator and strives to build meaningful relationships with people.

We look forward to seeing the impact Claudia will have on our mission to advance the next generation of antibody-based therapies. Welcome to the team, Claudia!

You can reach out to Claudia here.

Next
Next

AAX Biotech announces collaboration with research group at Karolinska Institutet on high-throughput characterization of novel TROP2-targeting antibodies